The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders
Open accessAbstract
High levels of impulsive behaviours are a clinically significant symptom in a range of psychiatric disorders, such as attention deficit hyperactivity disorder, bipolar disorder, personality disorders, pathological gambling and substance abuse. Although often measured using questionnaire assessments, levels of different types of impulsivity can also be determined using behavioural tests. Rodent analogues of these paradigms have been developed, and similar neural circuitry has been implicated in their performance in both humans and rats. In the current review, the methodology underlying the measurement of different aspects of impulsive action and choice are considered from the viewpoint of drug development, with a focus on the continuous performance task (CPT), stop‐signal task (SST), go/no‐go and delay‐discounting paradigms. Current issues impeding translation between animal and human studies are identified, and comparisons drawn between the acute effects of dopaminergic, noradrenergic and serotonergic compounds across species. Although the field could benefit from a more systematic determination of different pharmacological agents across paradigms, there are signs of strong concordance between the animal and human data. However, the type of impulsivity measured appears to play a significant role, with the SST and delay discounting providing more consistent effects for dopaminergic drugs, while the CPT and SST show better predictive validity so far for serotonergic and noradrenergic compounds. Based on the available data, it would appear that these impulsivity models could be used more widely to identify potential pharmacotherapies for impulse control disorders. Novel targets within the glutamatergic and serotonergic system are also suggested. LINKED ARTICLES This article is part of a themed issue on Translational Neuropharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐4
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insensitivity to future consequences following damage to human prefrontal cortex
Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994) · Cognition · doi:10.1016/0010-0277(94)90018-3 · Cited by 6,128
Psychiatric Aspects of Impulsivity
Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1783 · Cited by 2,747
Specious reward: A behavioral theory of impulsiveness and impulse control.
Ainslie, G. (1975) · Psychological Bulletin · doi:10.1037/h0076860 · Cited by 2,708 · cited 1×
“Delay-discounting tasks have probably been the most successful in terms of modelling the inability to prioritize future rewards over satisfying the need for more immediate gratification (Ainslie, 1975).”
BackgroundA continuous performance test of brain damage
Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome, E. D., & Beck, L. H. (1956) · Journal of Consulting Psychology · doi:10.1037/h0043220 · Cited by 2,261
Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls.
Kirby, K. N., Petry, N. M., & Bickel, W. K. (1999) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.128.1.78 · Cited by 2,171
Evenden, J. L. (1999) · Psychopharmacology · doi:10.1007/pl00005481 · Cited by 2,044 · cited 3×
“…may be expected when attempting to divide a broad concept such as impulsivity into distinct entities, there is some variation between what types of impulsivity should be considered both unique and representative of the construct (see Evenden, 1999; Winstanley et al., 2010a for discussion).”
BackgroundMethodJentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · cited 2×
“Furthermore, it is increasingly recognized that impulsivity is a vulnerability factor for substance abuse, and may facilitate relapse to drug-seeking and treatment failure (Jentsch and Taylor, 1999; Moeller et al., 2001b; Winstanley et al., 2010a).”
BackgroundSUBJECTIVE PROBABILITY AND DELAY
Rachlin, H., Raineri, A., & Cross, D. (1991) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1991.55-233 · Cited by 1,341
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 1×
“Such homogeneity is important in determining the validity of any animal model, and there have been a number of recent reviews summarizing this literature (Oquendo and Mann, 2000; Dalley et al., 2004; Winstanley et al., 2006; Eagle et al., 2008; Eagle and Baunez, 2010).”
BackgroundLinnoila, M., Virkkunen, M., Scheinin, M., Nuutila, A., Rimon, R., & Goodwin, F. K. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90344-2 · Cited by 1,308
Toward a behavioral economic understanding of drug dependence: delay discounting processes
Bickel, W. K., & Marsch, L. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961736.x · Cited by 1,117
Rubia, K., Russell, T., Overmeyer, S., Brammer, M. J., Bullmore, E. T., Sharma, T., Simmons, A., Williams, S. C. R., Giampietro, V., Andrew, C. M., et al. (2001) · NeuroImage · doi:10.1006/nimg.2000.0685 · Cited by 999 · cited 2×
“…that the types of inhibition taxed by these tasks – action cancellation in the SST, and action restraint in the go/no-go – can be dissociated both in terms of the supporting neural circuitry and the pharmacology of their regulation (Rubia et al., 2001; Eagle et al., 2008; Eagle and Baunez, 2010).”
BackgroundRole of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · cited 1×
“Indeed, the serotonergic contribution to ADHD is currently thought to be minimal, although amphetamine’s actions on the 5-HT system may contribute to its ‘paradoxical’ calming effect in ADHD (Gainetdinov et al., 1999).”
BackgroundVaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845 · cited 4×
“, 2003), go/no-go (Vaidya et al., 1998) and delay-discounting paradigm (Shiels et al.”
BackgroundInfluentialThe dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics
Sonuga-Barke, E. J. S. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.005 · Cited by 816 · cited 1×
“It is also quite well-established that individuals may have a primary deficit in one particular aspect of impulse control, and this may lead to the definition of subclasses of a illness such as in ADHD which may respond differently to drug treatments (Sonuga-Barke, 2003).”
BackgroundDopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684 · cited 2×
“Dysfunction within the DA system has been hypothesized to play a major role in psychiatric disorders such as ADHD (Ernst et al., 1998; Faraone and Biederman, 1998; Dougherty et al., 1999; Krause et al., 2000) and PG (Goudriaan et al.”
BackgroundSolanto, M. V., Abikoff, H., Sonuga-Barke, E., Schachar, R., Logan, G. D., Wigal, T., Hechtman, L., Hinshaw, S., & Turkel, E. (2001) · Journal of Abnormal Child Psychology · doi:10.1023/a:1010329714819 · Cited by 639 · cited 1×
“The results of such studies consistently indicate that deficits in many types of impulsivity coexist in psychiatric populations, and using behavioural tests to assess more than one impulsive behaviour has been shown to increase the accuracy of psychiatric diagnosis (Solanto et al., 2001).”
BackgroundDecision-making and addiction (part II): myopia for the future or hypersensitivity to reward?
Bechara, A., Dolan, S., & Hindes, A. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(02)00016-7 · Cited by 580 · cited 1×
“…is high tend to perform poorly on the IGT, as demonstrated by the increased preference for the disadvantageous decks in substance abusers (Bechara et al., 2001; 2002; Verdejo-Garcia et al., 2007a), pathological gamblers (Goudriaan et al., 2005), BPD patients (Haaland and Landro, 2007)…”
BackgroundNeurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · cited 4×
“However, comparing the available human and rodent studies, there appears to be considerable overlap between the effects of acute atomoxetine on tests of motor impulsivity, with a number of reports showing improved impulse control of this kind (Chamberlain et al., 2006; Blondeau and Dellu-Hagedorn, 2007; Robinson et al…”
BackgroundResultInfluentialEagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
The balloon analogue risk task (BART) differentiates smokers and nonsmokers.
Lejuez, C. W., Aklin, W. M., Jones, H. A., Richards, J. B., Strong, D. R., Kahler, C. W., & Read, J. P. (2003) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.11.1.26 · Cited by 523 · cited 2×
“Interestingly, scores on the IGT and BART again do not correlate, further indicating that risk-seeking, like impulsivity, may be multifaceted in nature (Lejuez et al., 2003).”
BackgroundKrause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · cited 2×
“Dysfunction within the DA system has been hypothesized to play a major role in psychiatric disorders such as ADHD (Ernst et al., 1998; Faraone and Biederman, 1998; Dougherty et al., 1999; Krause et al., 2000) and PG (Goudriaan et al.”
BackgroundImpaired inhibitory control of behavior in chronic cocaine users
Fillmore, M. T., & Rush, C. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00206-x · Cited by 519
Tripp, G., & Wickens, J. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.026 · Cited by 492
Substance abuse, pathological gambling, and impulsiveness
Petry, N. M. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00188-5 · Cited by 462 · cited 1×
“Furthermore, the poor IGT score observed in cocaine abusers and pathological gamblers does not correlate with any aspects of impulsivity as assessed by the BIS-11, unlike the number of commission errors made on the CPT (Petry, 2001; Kjome et al., 2010).”
MethodHarrison, A. A., Everitt, B. J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050410 · Cited by 452 · cited 9×
“D1 antagonist Harrison et al., 1997 ↓ ???”
BackgroundResultInfluentialAcute administration of d-amphetamine decreases impulsivity in healthy volunteers
de Wit, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00343-3 · Cited by 436 · cited 1×
“…(Table 1A: Rapoport et al., 1978; Sostek et al., 1980; Weingartner et al., 1980; Klorman et al., 1983; Barkley et al., 1991; Losier et al., 1996; Vaidya et al., 1998; de Wit et al., 2000; 2002; Fillmore et al., 2003; Wilson et al., 2006; Overtoom et al., 2009; Shiels et al., 2009; Li et al., 2010).”
Losier, B. J., McGrath, P. J., & Klein, R. M. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01494.x · Cited by 424
Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374
Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys
Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978) · Science · doi:10.1126/science.341313 · Cited by 373 · cited 1×
“…volunteers, acute administration of both amphetamine and methylphenidate has been shown to decrease impulsivity in all four paradigms (Table 1A: Rapoport et al., 1978; Sostek et al., 1980; Weingartner et al., 1980; Klorman et al., 1983; Barkley et al., 1991; Losier et al., 1996; Vaidya et al.,…”
BackgroundRobinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359
Measuring state changes in human delay discounting: an experiential discounting task
REYNOLDS, B., & SCHIFFBAUER, R. (2004) · Behavioural Processes · doi:10.1016/s0376-6357(04)00140-8 · Cited by 352
Pathological gambling: a comprehensive review of biobehavioral findings
Goudriaan, A. E., Oosterlaan, J., de Beurs, E., & Van den Brink, W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.001 · Cited by 313
Dopamine, Time, and Impulsivity in Humans
Pine, A., Shiner, T., Seymour, B., & Dolan, R. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6028-09.2010 · Cited by 300 · cited 2×
“Furthermore, administration of the DA precursor L-DOPA increases impulsive choice (Pine et al., 2010) in human volunteers, but does not affect SST or go/no-go performance (Overtoom et al., 2003; Hershey et al., 2004).”
BackgroundDel-Ben, C. M., Deakin, J. F. W., Mckie, S., Delvai, N. A., Williams, S. R., Elliott, R., Dolan, M., & Anderson, I. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300728 · Cited by 260 · cited 2×
“This observation fits with the fact that, regarding the effects of acute administration of serotonergic drugs, no significant effects have been reported on any behavioural test of impulsivity in healthy volunteers (Table 3A) (Hart et al., 1991; Del-Ben et al., 2005; Chamberlain et al., 2006; 2007; Wingen et al., 2007;…”
BackgroundResultLamm, C., Zelazo, P. D., & Lewis, M. D. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.10.013 · Cited by 254
Eagle, D. M., & Robbins, T. W. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1302 · Cited by 252
CHAPPELL, P. B., RIDDLE, M. A., SCAHILL, L., LYNCH, K. A., SCHULTZ, R., ARNSTEN, A., LECKMAN, J. F., & COHEN, D. J. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199509000-00010 · Cited by 250 · cited 2×
“Furthermore, guanfacine decreases premature responding in both the CPT (humans) (Chappell et al., 1995; Scahill et al., 2001) and 5CSRT (rats) (Milstein et al.”
BackgroundReynolds, B., Richards, J. B., & de Wit, H. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.01.007 · Cited by 247 · cited 1×
“Experiential delaydiscounting tasks have also been developed, in which subjects receive delays and rewards in real time, and which can be more sensitive to acute pharmacological manipulations (Reynolds and Schiffbauer, 2004; Reynolds et al., 2006).”
BackgroundImpulsivity predicts individual susceptibility to high levels of alcohol self-administration
Poulos, C. X., Le, A. D., & Parker, J. L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199512000-00006 · Cited by 234 · cited 1×
“…number of studies are considering individual differences in impulsive behaviour to be an important factor, and one that seems to significantly affect the response to drug challenges (e.g. Poulos et al., 1995; Feola et al., 2000; Dalley et al., 2007; Perry et al., 2008; Zeeb et al., 2010).”
BackgroundWinstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234 · cited 7×
“…although amphetamine has also been reported to have the opposite effect on the latter task (Evenden and Ryan, 1996; Cardinal et al., 2000; Stanis et al., 2008) – see Winstanley et al. (2003b) and Winstanley (2010) for discussion of methodological issues pertaining to these discrepant findings.”
BackgroundInfluentialSelf-citation(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1147 · Cited by 228
Higgins, G. A., Enderlin, M., Haman, M., & Fletcher, P. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1549-0 · Cited by 179
Eagle, D. M., Tufft, M. R. A., Goodchild, H. L., & Robbins, T. W. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0701-7 · Cited by 176
Clark, L., Roiser, J. P., Cools, R., Rubinsztein, D. C., Sahakian, B. J., & Robbins, T. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0104-6 · Cited by 175 · cited 1×
“In contrast, neither tryptophan depletion nor the 5-HT transporter polymorphism has been shown to affect the SSRT in healthy volunteers (Clark et al., 2005).”
BackgroundShiels, K., Hawk, L. W., Reynolds, B., Mazzullo, R. J., Rhodes, J. D., Pelham, W. E., Waxmonsky, J. G., & Gangloff, B. P. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0017259 · Cited by 146
Current Considerations in the Treatment of Generalized Anxiety Disorder
Katzman, M. A. (2009) · CNS Drugs · doi:10.2165/00023210-200923020-00002 · Cited by 128 · cited 3×
“5CSRT, five-choice serial reaction time task; 5-HT, serotonin; ADHD, attention deficit hyperactivity disorder; AMPA, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BART, Balloon Analogue Risk Task; BD, bipolar disorder; BIS-11, 11-point Barratt Impulsiveness Scale; BPD, borderline personality disorder; CPT,…”
BackgroundMethodPassetti, F., Dalley, J. W., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1227-7 · Cited by 121
WINSTANLEY, C. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1401.024 · Cited by 119
Self-citationSerotoninergic mechanisms in the treatment of obsessive–compulsive disorder
Goddard, A. W., Shekhar, A., Whiteman, A. F., & McDougle, C. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.009 · Cited by 112
Koskinen, T., Ruotsalainen, S., Puumala, T., Lappalainen, R., Koivisto, E., Männistö, P. T., & Sirviö, J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00159-8 · Cited by 108
Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder
Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., & Nunes, E. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n02_01 · Cited by 102
Milstein, J. A., Lehmann, O., Theobald, D. E. H., Dalley, J. W., & Robbins, T. W. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0594-x · Cited by 94
Winstanley, C. A., Zeeb, F. D., Bedard, A., Fu, K., Lai, B., Steele, C., & Wong, A. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.044 · Cited by 84 · cited 10×
“…agonists or antagonists do not appear to model amphetamine’s effects in rats; both D1 and D2 agonists decreased premature responding on the 5CSRT (Winstanley et al., 2010b), whereas administration of selective D2, D3 and D4 antagonists do not modulate any form of impulsivity tested (Evenden and…”
BackgroundMethodInfluentialSelf-citationLack of effects of guanfacine on executive and memory functions in healthy male volunteers
Müller, U., Clark, L., Lam, M. L., Moore, R. M., Murphy, C. L., Richmond, N. K., Sandhu, R. S., Wilkins, I. A., Menon, D. K., Sahakian, B. J., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0078-4 · Cited by 73
Cited by
Fineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction
Pascoli, V., Terrier, J., Hiver, A., & Lüscher, C. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.017 · Cited by 304
Dissecting impulsivity and its relationships to drug addictions
Jentsch, J. D., Ashenhurst, J. R., Cervantes, M. C., Groman, S. M., James, A. S., & Pennington, Z. T. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12388 · Cited by 281
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Metadata
- Authors
- Winstanley, C. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 164
- Issue
- 4
- Pages
- 1301-1321
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1895018411
- Cited by
- 218
- References
- 55
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.